GB9920912D0 - Novel derivatives of flavones,xanthones and coumarins - Google Patents

Novel derivatives of flavones,xanthones and coumarins

Info

Publication number
GB9920912D0
GB9920912D0 GBGB9920912.4A GB9920912A GB9920912D0 GB 9920912 D0 GB9920912 D0 GB 9920912D0 GB 9920912 A GB9920912 A GB 9920912A GB 9920912 D0 GB9920912 D0 GB 9920912D0
Authority
GB
United Kingdom
Prior art keywords
xanthones
coumarins
flavones
compounds
novel derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9920912.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Priority to GBGB9920912.4A priority Critical patent/GB9920912D0/en
Publication of GB9920912D0 publication Critical patent/GB9920912D0/en
Priority to RU2002108565/04A priority patent/RU2252221C2/ru
Priority to PT00958505T priority patent/PT1212312E/pt
Priority to EP00958505A priority patent/EP1212312B1/en
Priority to CA2382129A priority patent/CA2382129C/en
Priority to DE60001974T priority patent/DE60001974T2/de
Priority to DK00958505T priority patent/DK1212312T3/da
Priority to PCT/EP2000/008365 priority patent/WO2001017985A1/en
Priority to CNB008121818A priority patent/CN1229370C/zh
Priority to CZ20020785A priority patent/CZ300939B6/cs
Priority to HK02105077.3A priority patent/HK1043368B/en
Priority to ES00958505T priority patent/ES2195933T3/es
Priority to PL356699A priority patent/PL211887B1/pl
Priority to HU0202578A priority patent/HUP0202578A3/hu
Priority to KR1020027002800A priority patent/KR100819575B1/ko
Priority to SK309-2002A priority patent/SK286402B6/sk
Priority to AT00958505T priority patent/ATE236147T1/de
Priority to AU70000/00A priority patent/AU775790B2/en
Priority to SI200030117T priority patent/SI1212312T1/xx
Priority to JP2001521732A priority patent/JP4782337B2/ja
Priority to US10/075,628 priority patent/US6608089B2/en
Priority to NO20021050A priority patent/NO327911B1/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
GBGB9920912.4A 1999-09-03 1999-09-03 Novel derivatives of flavones,xanthones and coumarins Ceased GB9920912D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB9920912.4A GB9920912D0 (en) 1999-09-03 1999-09-03 Novel derivatives of flavones,xanthones and coumarins
JP2001521732A JP4782337B2 (ja) 1999-09-03 2000-08-28 フラボン類、キサントン類およびクマリン類の新規誘導体
HK02105077.3A HK1043368B (en) 1999-09-03 2000-08-28 Novel derivatives of flavones, xanthones and coumarins
PL356699A PL211887B1 (pl) 1999-09-03 2000-08-28 Pochodne flawonów, ksantonów i kumaryn, ich zastosowanie i kompozycja farmaceutyczna je zawierająca
EP00958505A EP1212312B1 (en) 1999-09-03 2000-08-28 Novel derivatives of flavones, xanthones and coumarins
CA2382129A CA2382129C (en) 1999-09-03 2000-08-28 Novel derivatives of flavones, xanthones and coumarins
DE60001974T DE60001974T2 (de) 1999-09-03 2000-08-28 Derivate von flavonen, xanthonen und kumarinen
DK00958505T DK1212312T3 (da) 1999-09-03 2000-08-28 Hidtil ukendte derivater af flavoner, xanthoner og coumariner
PCT/EP2000/008365 WO2001017985A1 (en) 1999-09-03 2000-08-28 Novel derivatives of flavones, xanthones and coumarins
CNB008121818A CN1229370C (zh) 1999-09-03 2000-08-28 黄酮类、呫吨酮类和香豆素类衍生物
CZ20020785A CZ300939B6 (cs) 1999-09-03 2000-08-28 Nové deriváty flavonu, xantonu a kumarinu
RU2002108565/04A RU2252221C2 (ru) 1999-09-03 2000-08-28 Производные флавонов, ксантонов и кумаринов и фармацевтическая композиция на их основе
ES00958505T ES2195933T3 (es) 1999-09-03 2000-08-28 Nuevos derivados de flavonas, xantonas y cumarinas.
PT00958505T PT1212312E (pt) 1999-09-03 2000-08-28 Novos derivados de flavonas xantonas e cumarinas
HU0202578A HUP0202578A3 (en) 1999-09-03 2000-08-28 Novel derivatives of flavones, xanthones and coumarins
KR1020027002800A KR100819575B1 (ko) 1999-09-03 2000-08-28 플라본, 잔톤 및 쿠마린의 신규 유도체
SK309-2002A SK286402B6 (sk) 1999-09-03 2000-08-28 Deriváty flavónov, xantónov a kumarínov, farmaceutický prostriedok s ich obsahom a ich použitie
AT00958505T ATE236147T1 (de) 1999-09-03 2000-08-28 Derivate von flavonen, xanthonen und kumarinen
AU70000/00A AU775790B2 (en) 1999-09-03 2000-08-28 Novel derivatives of flavones, xanthones and coumarins
SI200030117T SI1212312T1 (en) 1999-09-03 2000-08-28 Novel derivatives of flavones, xanthones and coumarins
US10/075,628 US6608089B2 (en) 1999-09-03 2002-02-15 Derivatives of flavones, xanthones and coumarins
NO20021050A NO327911B1 (no) 1999-09-03 2002-03-01 Nye derivater av flavoner, xantoner og kumariner, anvendelser derav, og farmasoytiske preparater omfattende slike

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920912.4A GB9920912D0 (en) 1999-09-03 1999-09-03 Novel derivatives of flavones,xanthones and coumarins

Publications (1)

Publication Number Publication Date
GB9920912D0 true GB9920912D0 (en) 1999-11-10

Family

ID=10860348

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9920912.4A Ceased GB9920912D0 (en) 1999-09-03 1999-09-03 Novel derivatives of flavones,xanthones and coumarins

Country Status (20)

Country Link
US (1) US6608089B2 (enExample)
EP (1) EP1212312B1 (enExample)
JP (1) JP4782337B2 (enExample)
KR (1) KR100819575B1 (enExample)
CN (1) CN1229370C (enExample)
AT (1) ATE236147T1 (enExample)
AU (1) AU775790B2 (enExample)
CA (1) CA2382129C (enExample)
CZ (1) CZ300939B6 (enExample)
DE (1) DE60001974T2 (enExample)
DK (1) DK1212312T3 (enExample)
ES (1) ES2195933T3 (enExample)
GB (1) GB9920912D0 (enExample)
HU (1) HUP0202578A3 (enExample)
NO (1) NO327911B1 (enExample)
PL (1) PL211887B1 (enExample)
PT (1) PT1212312E (enExample)
RU (1) RU2252221C2 (enExample)
SK (1) SK286402B6 (enExample)
WO (1) WO2001017985A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020500A2 (en) 2000-09-01 2002-03-14 Icos Corporation Materials and methods to potentiate cancer treatment
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
JP4664597B2 (ja) 2002-04-17 2011-04-06 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
ATE423110T1 (de) 2002-07-17 2009-03-15 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
EP1553911B1 (en) * 2002-08-02 2010-06-23 The Ohio State University Research Foundation 2-heterosubstituted 3-aryl-4-h-1-benzopyran-4-ones as novel therapeutics in breast cancer
WO2004024086A2 (en) * 2002-09-13 2004-03-25 Cytokinetics, Inc. Compounds, compositions and methods
KR20050095859A (ko) * 2003-02-04 2005-10-04 가부시키가이샤 야쿠루트 혼샤 유방암 내성 단백 저해제
US8404681B2 (en) 2003-03-24 2013-03-26 Luitpold Pharmaceuticals, Inc. Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
JP2007507539A (ja) * 2003-10-06 2007-03-29 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
GB0412768D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
FR2929276B1 (fr) * 2008-04-01 2010-04-23 Servier Lab Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN101497593B (zh) * 2009-03-18 2011-09-21 华南理工大学 5-羟基香豆素和吡喃型香豆素类化合物及合成方法与应用
EP2560652A4 (en) * 2010-04-23 2013-08-14 Kineta Inc ANTIVIRAL CONNECTIONS
CN101985449B (zh) * 2010-09-28 2012-08-22 中山大学 一种香豆素衍生物及其制备方法和作为抗癌药物的用途
CN103113340B (zh) * 2013-01-21 2015-08-19 四川大学 一类金雀异黄酮烷基胺类化合物、其制备方法和用途
CN103232462B (zh) * 2013-05-13 2016-03-02 湖北科技学院 香豆素-吡咯类化合物的合成方法
CN103408554B (zh) * 2013-07-31 2015-07-08 西安交通大学 一种具有降高血压活性的吡咯香豆素类化合物及制备方法
CN104274455B (zh) * 2014-09-24 2018-04-27 山东理工大学 含苄基哌嗪槲皮素衍生物制法及其对胃黏膜保护作用
CN107641109B (zh) * 2017-10-16 2019-05-24 厦门大学 一种类黄酮化合物及其制备方法和应用
CN107602520B (zh) * 2017-10-16 2019-06-14 厦门大学 一种含哌嗪环的类异黄酮化合物及其制备方法和应用
KR102109151B1 (ko) 2018-06-28 2020-05-11 영남대학교 산학협력단 잔톤 유도체의 신규한 제조방법, 이로 제조된 신규한 잔톤 유도체 및 이들을 포함하는 조성물
CN110156735B (zh) * 2019-04-23 2023-05-12 天津国际生物医药联合研究院 芒柄花黄素衍生物及其制备方法和应用
CN110240579B (zh) * 2019-06-10 2023-03-31 中国科学院成都有机化学有限公司 一种多取代γ-丁内酯类化合物、制备方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3513198A (en) * 1965-10-22 1970-05-19 Hoffmann La Roche Aryloxy- and arylthio-acetylenic amines and the salts thereof
FR2378519B1 (enExample) * 1976-11-24 1982-08-06 Unicler
JPH03163017A (ja) * 1989-08-24 1991-07-15 Nisshin Flour Milling Co Ltd 抗癌活性増強剤
US5023341A (en) 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US5399561A (en) 1989-09-19 1995-03-21 Allergan, Inc. Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
JP2514500B2 (ja) * 1991-09-14 1996-07-10 呉羽化学工業株式会社 多剤耐性抑制剤及び発現阻害剤
US5663179A (en) * 1992-07-10 1997-09-02 Laboratoires Glaxo Sa Certain isoquinoline derivatives having anti-tumor properties
DE4323409A1 (de) * 1993-07-13 1995-01-19 Boehringer Mannheim Gmbh Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
US5852033A (en) * 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
JPH1036260A (ja) * 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法

Also Published As

Publication number Publication date
CZ300939B6 (cs) 2009-09-16
DE60001974T2 (de) 2004-02-19
US6608089B2 (en) 2003-08-19
NO20021050L (no) 2002-05-03
PT1212312E (pt) 2003-08-29
PL211887B1 (pl) 2012-07-31
KR100819575B1 (ko) 2008-04-04
SK286402B6 (sk) 2008-09-05
DE60001974D1 (de) 2003-05-08
CA2382129A1 (en) 2001-03-15
AU7000000A (en) 2001-04-10
HUP0202578A2 (hu) 2002-11-28
ES2195933T3 (es) 2003-12-16
DK1212312T3 (da) 2003-07-21
EP1212312A1 (en) 2002-06-12
RU2252221C2 (ru) 2005-05-20
HUP0202578A3 (en) 2005-02-28
NO20021050D0 (no) 2002-03-01
CZ2002785A3 (cs) 2002-06-12
NO327911B1 (no) 2009-10-19
WO2001017985A1 (en) 2001-03-15
SK3092002A3 (en) 2003-10-07
US20020183318A1 (en) 2002-12-05
JP2003508524A (ja) 2003-03-04
KR20020030801A (ko) 2002-04-25
HK1043368A1 (en) 2002-09-13
PL356699A1 (en) 2004-06-28
ATE236147T1 (de) 2003-04-15
CA2382129C (en) 2010-07-06
EP1212312B1 (en) 2003-04-02
CN1229370C (zh) 2005-11-30
JP4782337B2 (ja) 2011-09-28
CN1371371A (zh) 2002-09-25
AU775790B2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
PL356699A1 (en) Novel derivatives of flavones, xanthones and coumarins
MXPA05009985A (es) Ligandos de receptores de canabinoides.
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
NZ507221A (en) Antitumor agent
IL149186A0 (en) Pharmaceutical compositions providing enhanced drug concentrations
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
HUP0400200A3 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
MXPA03010761A (es) Combinaciones farmaceuticas.
GB0109122D0 (en) Novel compounds
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
WO2002070515A3 (en) Chromane derivatives, process for their preparation and their use as antitumor agents
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
IL154755A0 (en) Antitumor theraphy comprising distamycin derivatives
IL165086A (en) Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
HUP0202016A3 (en) Taxane derivatives, the use of them for producing anti-cancer medicaments, these medicaments and processes for preparation of these derivatives
MY133682A (en) Substituted pyrroles
EE04525B1 (et) Morfoliini derivaadid, nende valmistamismeetod janeid sisaldavad farmatseutilised kompositsioonid
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.
TW200633701A (en) Thioether derivatives, their manufacture and use as pharmaceutical agents
GB0122257D0 (en) Simplified sarcodictyin derivatives
DK1165596T3 (da) 14,15-alfa-methylen-equileninderivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)